Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study-Reference-Cited by-同舟云学术

Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study

Published:2021-07 Issue:7 Volume:22 Page:946-958
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Lee Chung-Han,Shah Amishi Yogesh,Rasco Drew,Rao Arpit,Taylor Matthew H,Di Simone Christopher,Hsieh James J,Pinto Alvaro,Shaffer David R,Girones Sarrio Regina,Cohn Allen Lee,Vogelzang Nicholas J,Bilen Mehmet Asim,Gunnestad Ribe Sara,Goksel Musaberk,Tennøe Øyvind Krohn,Richards Donald,Sweis Randy F,Courtright Jay,Heinrich Daniel,Jain Sharad,Wu Jane,Schmidt Emmett V,Perini Rodolfo F,Kubiak Peter,Okpara Chinyere E,Smith Alan D,Motzer Robert J

Funder

NIH

Publisher

Elsevier BV

Subject

Oncology

Reference25 articles.

1. Systemic therapy for metastatic renal-cell carcinoma;Choueiri;N Engl J Med,2017

2. Renal cell carcinoma;Hsieh;Nat Rev Dis Primers,2017

3. Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma;Motzer;N Engl J Med,2019

4. Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma;Rini;N Engl J Med,2019

5. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma;Motzer;N Engl J Med,2018

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment options for tumor progression after initial immunotherapy in advanced non-small cell lung cancer: A real-world study;Neoplasia;2024-11

2. Abscopal effect following checkpoint inhibitor therapy and localized radiotherapy for metastatic clear cell renal cell carcinoma: A case report;Urology Case Reports;2024-09

3. Lenvatinib in combination with pembrolizumab in heavily pretreated metastatic thymic carcinoma: A case report;Current Problems in Cancer: Case Reports;2024-09

4. Rechallenging with anti-PD-1 therapy in advanced renal cell carcinoma;The Lancet;2024-09

5. Oncolytic viruses facilitate tumor immunotherapy;SCIENTIA SINICA Vitae;2024-09-01